Skip to main content
Equibles

UBS Group AG

Position in AMGN — Amgen Inc

CIK 1610520 ZURICH, V8
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,198,144,628
+$90,506,758 QoQ
Shares Held
3,308,695
+5.1% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#26
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 31% Shared 0% None 69%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Jun 30, 2026
CallValue
$4,526,500
CallShares
12,500
PutValue
$4,526,500
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. AMGN ranks #5 (7.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 3,865,931 $4,636,914,000
2 ABBV
AbbVie Inc.
 12,845,120 $3,232,345,993
3 JNJ
Johnson & Johnson
 11,036,891 $2,803,039,201
4 MRK
Merck & Co., Inc.
 13,744,783 $1,766,204,613
5 AMGN
Amgen Inc
This page 		3,308,695 $1,198,144,628
6 AZN
Astrazeneca PLC
 5,297,462 $1,004,504,738
7 GILD
Gilead Sciences, Inc.
 4,503,294 $568,946,162
8 BMY
Bristol Myers Squibb Co
 8,876,439 $511,460,413

All Filings in AMGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,526,500 12,500
2026-06-30 $1,198,144,628 3,308,695
2026-06-30 $4,526,500 12,500
2026-03-31 $22,936,397 65,188
2026-03-31 $1,107,637,870 3,148,040
2026-03-31 $21,849,885 62,100
2025-12-31 $1,343,451,744 4,104,524
2025-12-31 $10,244,803 31,300
2025-12-31 $14,430,443 44,088
2025-09-30 $12,078,160 42,800
2025-09-30 $14,420,420 51,100
2025-09-30 $1,194,483,176 4,232,754
2025-06-30 $4,076,466 14,600
2025-06-30 $1,278,130,679 4,577,668
2025-06-30 $18,651,228 66,800
2025-03-31 $5,483,280 17,600
2025-03-31 $1,397,736,357 4,486,395
2025-03-31 $2,710,485 8,700
2024-12-31 $18,140,544 69,600
2024-12-31 $1,060,182,906 4,067,614
2024-12-31 $28,175,184 108,100
2024-09-30 $48,234,837 149,700
2024-09-30 $63,443,149 196,900
2024-09-30 $1,162,127,047 3,606,738
2024-06-30 $36,089,224 115,504
2024-06-30 $1,161,273,847 3,716,671
2024-06-30 $48,273,525 154,500
2024-03-31 $1,065,520,470 3,747,610
2024-03-31 $37,757,696 132,800
2024-03-31 $21,892,640 77,000
2023-12-31 $87,971,388 305,435
2023-12-31 $967,899,269 3,360,528
2023-12-31 $101,405,217 352,077
2023-09-30 $110,836,624 412,400
2023-09-30 $39,642,100 147,500
2023-09-30 $783,843,910 2,916,520
2023-06-30 $34,790,534 156,700
2023-06-30 $145,844,938 656,900
2023-06-30 $721,844,741 3,251,260
2023-03-31 $32,853,825 135,900
2023-03-31 $913,620,873 3,779,197
2023-03-31 $61,477,025 254,300
2022-12-31 $1,009,362,810 3,843,142
2022-12-31 $83,729,632 318,800
2022-12-31 $43,230,544 164,600
2022-09-30 $25,087,020 111,300
2022-09-30 $756,542,699 3,356,445
2022-09-30 $51,323,580 227,700
2022-06-30 $50,728,050 208,500
2022-06-30 $871,124,455 3,580,454

Report a Problem

Category
Description
Email (optional, for follow-up)